Officina Stellare S.p.A. (IT:OS) has released an update. Officina Stellare has secured a €1.4 million contract to develop a high-resolution ...
What Factors Have Led to iTeos Therapeutics Inc (ITOS) Stock Trading -53.01% Below Its 52-Week High?
On Friday, iTeos Therapeutics Inc (ITOS) stock saw a modest uptick, ending the day at $8.81 which represents a slight increase of $0.36 or 4.26% from the prior close of $8.45. The stock opened at ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
This page features the latest news about the Iteos stock. Iteos Therapeutics stock hits 52-week low at $8.49 Iteos Therapeutics Inc. (NASDAQ: ITOS) stock has reached a 52-week low, touching down ...
Featured here, the Income Statement (earnings report) for Iteos Therapeutics Inc, showing the company's financial performance from operating and non operating activities such as revenue ...
You'll find Call and Put Strike Prices, Last Price, Change, Volume, Implied Volatility, Theoretical and Greeks for Iteos options for the expiration dates selected. Below this information you can also ...
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 4,820,000 shares ...
Wells Fargo has recently initiated iTeos Therapeutics Inc (ITOS) stock to Overweight rating, as announced on August 13, 2024, according to Finviz. Earlier, on May 5, 2021, H.C. Wainwright had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback